 |
 |
Comments on Paper and Primary News |
 |
  |
| |
Comment by: George Perry (Disclosure)
|
 |
 |
Submitted 5 November 2009
| Permalink
|
Posted 6 November 2009
|
 |
 |
I recommend this paper
|
 |
 |
| |
Submit a Comment on this Paper |
 |
 |
 |
 |
| |
 |
 |
| |
REAGENTS/MATERIAL:
Primary Antibodies used in this study:
rabbit anti-human APP (Affinity Bioreagents, Golden, CO);
mouse monoclonal anti-Aβ (BAM01 or 6F/3D) cross-reacts with APP (Neomarkers, Fremont, CA);
mouse monoclonal anti-Aβ (6E10) cross-reacts with APP (Covance Research Products, Denver, PA);
mouse monoclonal anti-Aβ42 (12F4) (Signet Covance);
mouse monoclonal anti-Aβ40 (5C3) (Assay Designs Stressgen, Ann Arbor, MI);
mouse monoclonal anti-GFAP (GA5) a marker for astrocytes or Müller cells (Sigma-Aldrich);
rabbit anti-IBA1, a marker for microglia (Biocare Medical, Concord, CA);
mouse monoclonal anti-hyperphosphorylated tau (AT8) (Pierce Thermo Scientific, Rockford, IL) and
rabbit anti-von Willebrand factor (Sigma-Aldrich)
|
|
|
 |